CASH FLOWS FROM OPERATING ACTIVITIES: | |
Net loss | -1.5M |
Adjustments to reconcile net loss to net cash used by operating activities: | |
Allowance for doubtful accounts | |
Depreciation and amortization of fixed assets | 16K |
Amortization of deferred financing costs and other assets | 10K |
Gain on fair value of warrant liabilities | -27K |
Accretion of asset retirement obligation | 7K |
Share-based compensation | 70K |
Changes in operating assets and liabilities: | |
Accounts receivable, gross | 31K |
Inventory | -39K |
Other receivables | |
Prepaid expenses and other current assets | 41K |
Accounts payable and accrued expenses | -118K |
Accrued protocol expense | 28K |
Accrued radioactive waste disposal | 12K |
Accrued payroll and related taxes | 98K |
Accrued vacation | 11K |
Net cash used by operating activities | |
CASH FLOWS FROM INVESTING ACTIVITIES: | |
Purchases of fixed assets | -147K |
Additions to licenses and other assets | -151K |
Change in restricted cash | |
Net cash used by investing activities | |
CASH FLOWS FROM FINANCING ACTIVITIES: | |
Principal payments on notes payable | |
Preferred dividends paid | |
Proceeds from sales of common stock, pursuant to registered direct offering | |
Proceeds from sales of common stock, pursuant to ATM | |
Proceeds from sales of common stock, pursuant to exercise of warrants | |
Proceeds from sales of common stock, pursuant to exercise of options | 0 |
Cash payment on stock offering costs | |
Net cash provided by financing activities | |
Net increase in cash and cash equivalents | -1.68M |
Cash and cash equivalents, beginning of period | 10.14M |
CASH AND CASH EQUIVALENTS, END OF PERIOD | 8.46M |
Non-cash investing and financing activities: | |
Initial fair value of warrant liabilities |